![]() |
Trials |
A Phase Ib/II Randomized Study of BI 836845 in Combination with Exemestane and Everolimus Versus Exemestane and Everolimus Alone in Women with Locally Advanced or Metastatic Breast CancerCancer type: Breast cancer Phase: I/II Principal Investigator: Xie Hanjing Country: SE Keywords: Sweden, Karolinska Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/show/NCT02123823 |